Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 5
Submit an article Journal homepage
136
Views
8
CrossRef citations to date
0
Altmetric
Letters to the Editor

Infrequent occurrence of PIK3CA mutations in chronic lymphocytic leukemia

Millaray Marincevic Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
,
Gerard Tobin Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
&
Richard Rosenquist Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
, MD, PhD
Pages 829-830 | Received 07 Dec 2008, Accepted 05 Feb 2009, Published online: 21 Jul 2009

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wenli Cui, Shutao Zheng, Zebing Liu, Weige Wang, Ying Cai, Rui Bi, Bing Cao & Xiaoyan Zhou. (2017) PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro. OncoTargets and Therapy 10, pages 2239-2247.
Read now

Articles from other publishers (7)

Benjamin L. Lampson & Jennifer R. Brown. (2021) The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia. Hematology/Oncology Clinics of North America 35:4, pages 807-826.
Crossref
Anshul Kumar, Rohit Bhatia, Pooja Chawla, Durgadas Anghore, Vipin Saini & Ravindra K. Rawal. (2020) Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma. Anti-Cancer Agents in Medicinal Chemistry 20:10, pages 1158-1172.
Crossref
Chiara Tarantelli, Antonio Lupia, Anastasios Stathis & Francesco Bertoni. (2020) Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?. International Journal of Molecular Sciences 21:3, pages 1060.
Crossref
M. Dreyling, F. Morschhauser, K. Bouabdallah, D. Bron, D. Cunningham, S.E. Assouline, G. Verhoef, K. Linton, C. Thieblemont, U. Vitolo, F. Hiemeyer, M. Giurescu, J. Garcia-Vargas, I. Gorbatchevsky, L. Liu, K. Koechert, C. Peña, M. Neves, B.H. Childs & P.L. Zinzani. (2017) Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma. Annals of Oncology 28:9, pages 2169-2178.
Crossref
Jennifer R. Brown, Matthew S. Davids, Jordi Rodon, Pau Abrisqueta, Siddha N. Kasar, Joanne Lager, Jason Jiang, Coumaran Egile & Farrukh T. Awan. (2015) Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma. Clinical Cancer Research 21:14, pages 3160-3169.
Crossref
M Suljagic, L Laurenti, M Tarnani, M Alam, S N Malek & D G Efremov. (2010) Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells. Leukemia 24:12, pages 2063-2071.
Crossref
Roberta R. Ruela-de-Sousa, Karla C.S. Queiroz, Maikel P. Peppelenbosch & Gwenny M. Fuhler. (2010) Reversible phosphorylation in haematological malignancies: Potential role for protein tyrosine phosphatases in treatment?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1806:2, pages 287-303.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.